Released Jun 16, 2014, after the close
10-Q filed Jun 16, 2014, 47 days after period end · 0001354488-14-003317
Q2 2014 · 10-Q
Revenue—
Net Income$327.78K$327.78K −76.4% vs Q2 2013−50.5% vs Q1 2014
EPS Diluted$0.01$0.01 −76.3% vs Q2 2013−50.0% vs Q1 2014
Gross Profit$2,089,914−33.1%
Operating Income$419,263−76.0%
Operating Cash Flow-$882,222N/M
Free Cash Flowderived-$947,834N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | $327.78K | $1.39M | $1.19M | $479.69K |
| EPS Diluted | $0.01 | $0.06 | $0.05 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR